| mRNA |
SGX-523 |
CTRPv2 |
pan-cancer |
AAC |
0.31 |
1e-17 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
2e-11 |
| mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
7e-09 |
| mRNA |
MGCD-265 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-07 |
| mRNA |
CP724714 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
2e-07 |
| mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-06 |
| mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
| mRNA |
foretinib |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
6e-05 |
| mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
8e-05 |
| mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |